Searchable abstracts of presentations at key conferences in endocrinology

ea0029s28.2 | Osteoporosis treatment in 2012 and beyond | ICEECE2012

Sclerostin: a key bone regulatory molecule

Robinson M.

Sclerostin is an osteocyte-expressed, extracellular cystine-knot protein that is lacking in patients with sclerosteosis, a rare condition characterized by excessive bone formation. Sclerosteosis patients exhibit very high bone mass (lumbar spine Z scores up to +14) and are anecdotally resistant to bone fracture. Homozygous patients commonly develop symptoms associated with cranial nerve entrapment from excessive bone formation but do not show signs of heterotopic bone formatio...